
Vogenx
VOGXPro trackingVogenx, Inc. · Nasdaq · Clinical-stage biotechnology · Research source · 424B4 · Research as of 2026/08/12 · Latest filing · 10-Q · 2026-11-06 SEC ↗ · SEC checked 2026-11-21
Saved research available · 424B4
Vogenx is offering 6,250,000 common shares at $13.00 per share under Nasdaq symbol VOGX.
Updates and this research have separate source dates; newer facts do not silently replace earlier conclusions.
Newly listed — review valuation, deal quality and post-IPO supply before acting
A clinical-stage developer of therapies for metabolic disorders including post-bariatric hypoglycemia. The IPO priced at $13.00 and raised $81.25M.
Full source-backed summary
A clinical-stage developer of therapies for metabolic disorders including post-bariatric hypoglycemia. The IPO priced at $13.00 and raised $81.25M. The latest market-value reference is $410.85M; reported revenue is Pre-revenue and net result is $(1.56M). The offer figures are reconciled to the final prospectus.
- Business and development direction
A clinical-stage developer of therapies for metabolic disorders including post-bariatric hypoglycemia.
Current business Clinical-stage biotechnology100%
Future development Future direction not yet disclosed
Key risks
Risk 1
Clinical development, regulatory approval and cash-runway outcomes can change the equity value materially.
Risk 2
The latest reported period remains loss-making.
Risk 3
The primary-secondary mix, controlling holders and voting rights require the final beneficial-ownership table.
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Offering quality | This saved report has no compatible source inputs for this calculation. Open filing ↗ |
| # | Institution | Underwriting allocation | Ratio · calculated | Shares |
|---|---|---|---|---|
| 1 | JonesTrading Institutional Services LLC | 100.00% | 6,250,000 shares |
Ratio = institution commitment ÷ complete source-table total (6,250,000 shares) × 100.
Underwriting terms
| Measure | Reported value | Unit |
|---|---|---|
| Underwriting discount per share | $0.91 | $ / share |
| Total underwriting discount | $5,687,500 | $ |
Source and calculation
Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 2 row 3; source 4091:6298; SHA256 d173ebfc848860db950e17153f38d8f10ad082b725fb28faad2406ea728524ad ↗Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 2 row 3; source 4091:6298; SHA256 d173ebfc848860db950e17153f38d8f10ad082b725fb28faad2406ea728524ad ↗IPO CAPITAL QUALITY
Basis and evidence
No estimate is substituted for missing offer terms.
Capital quality is not yet quantifiable from the filed terms. IPO177 will calculate it when primary/secondary shares, fees and net proceeds are all disclosed.
Offering structure
| Measure | Reported value | Unit |
|---|---|---|
| Offering price | $13 | $ / share |
| Gross offering amount | $81,250,000 | $ |
Source and calculation
Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 2 row 2; source 4091:6298; SHA256 d173ebfc848860db950e17153f38d8f10ad082b725fb28faad2406ea728524ad ↗Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 2 row 2; source 4091:6298; SHA256 d173ebfc848860db950e17153f38d8f10ad082b725fb28faad2406ea728524ad ↗Proceeds and intended uses
| Measure | Reported value | Unit |
|---|---|---|
| Issuer proceeds before expenses | $75,562,500 | $ |
Source and calculation
Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
SEC table 2 row 4; source 4091:6298; SHA256 d173ebfc848860db950e17153f38d8f10ad082b725fb28faad2406ea728524ad ↗Dilution and valuation
| Calculation | Shares | Value | Reference |
|---|---|---|---|
| Base post-offer valuation | ≈ 13.9176M | ≈ $180.9286M | |
| Post-offer shares — base/no option | 13,917,587 | — | |
| Post-offer shares — full option | 14,855,087 | — | |
| Capitalization shares — actual | 5,263,158 | — | |
| Capitalization shares — pro forma | 7,667,587 | — | |
| Capitalization shares — pro forma as adjusted | 13,917,587 | — | |
| Offering price | — | $13 | |
| Gross offering amount | — | $81,250,000 |
Basis and evidence ↗
Prospectus share summary; Shares of our common stock to be outstanding after this offering; 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Prospectus share summary; Shares of our common stock to be outstanding after this offering; 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: full option; no inferred sum, conversion or equity value
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: actual; Common stock, $0.0001 par value; 50,000,000 shares authorized, 5,263,158 shares issued and outstanding, actual; 500,000,000 shares authorized, pro forma and pro forma as adjusted; 7,667,587 shares issued and outstanding, pro forma; 13,917,587 shares issued and outstanding, pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: pro forma; Common stock, $0.0001 par value; 50,000,000 shares authorized, 5,263,158 shares issued and outstanding, actual; 500,000,000 shares authorized, pro forma and pro forma as adjusted; 7,667,587 shares issued and outstanding, pro forma; 13,917,587 shares issued and outstanding, pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Capitalization share count; source stage: pro forma as adjusted; Common stock, $0.0001 par value; 50,000,000 shares authorized, 5,263,158 shares issued and outstanding, actual; 500,000,000 shares authorized, pro forma and pro forma as adjusted; 7,667,587 shares issued and outstanding, pro forma; 13,917,587 shares issued and outstanding, pro forma as adjusted; this stage is not reclassified as an IPO equity-value denominator
Figures retain their stated source scenario and conditions.
Base prospectus offering; cover per-share and total columns
Base prospectus offering; cover per-share and total columns Figures retain their stated source scenario and conditions.
completion-of-this-offering
Base prospectus offering; cover per-share and total columns
Prospectus share summary; Shares of our common stock to be outstanding after this offering; 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value
Exact input · Offering price: $13
Exact input · Post-offer shares — base/no option: 13,917,587
Prospectus share summary; Shares of our common stock to be outstanding after this offering; 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: full option; no inferred sum, conversion or equity value
Exact input · Post-offer shares — full option: 14,855,087
completion-of-this-offering
Base prospectus offering; cover per-share and total columns
Prospectus share summary; Shares of our common stock to be outstanding after this offering; 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value
completion-of-this-offering
Base prospectus offering; cover per-share and total columns
Prospectus share summary; Shares of our common stock to be outstanding after this offering; 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value
Prospectus share summary; Shares of our common stock to be outstanding after this offering; 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value
Base prospectus offering; cover per-share and total columns
Prospectus share summary; Shares of our common stock to be outstanding after this offering; 13,917,587 shares (or 14,855,087 shares if the underwriters exercise their option to purchase additional shares in full).; selected security: shares; selected scenario: base/no option; no inferred sum, conversion or equity value
Exact input · Post-offer shares — base/no option: 13,917,587
Exact input · Offering price: $13
Share-count comparison
A compatible whole-issuer pre-offer share count is missing; existing-holder or offered-share allocations cannot substitute for it.
Source ↗IPO valuation scenario simulator
Offering completion · $13 × ≈ 13.9176M shares · Final
Source and calculation ↗
Reported point prices retain their security, class, currency and per-security unit; range endpoints remain separate.
Reported whole-issuer base counts retain explicit option, conversion and surrender assumptions.
Equity value is the exact product of the selected compatible per-share price and whole-issuer post-offer count.
A compatible whole-issuer pre-offer share count is missing; existing-holder or offered-share allocations cannot substitute for it.
Each reported full-option, actual, diluted or class-specific case remains independent; no class sum or cross-date substitution is inferred.
The exact selected base supports transparent hypothetical price/share changes; it is not a forecast or tradable float.
The current source URL, accession, hash, proof variants, footnotes, input IDs and executable formulas remain attached. Missing source dates and precision gaps remain explicit.
These saved displays are not verified valuation inputs. Their stage, precision and assumptions have not been established by the current source.
IPO price · 6.250M · $81.25M · $13.00
Latest shares outstanding · 13.92M · $410.85M · Market snapshot
Revenue reference · — · Pre-revenue · —
Net-result reference · — · $(1.56M) · Loss-making
$13 × 13,917,587 = $180,928,631 [summary-table-45-base-4-price, summary-table-45-base-4-post]
Exact calculation · Derived whole-issuer equity value: $180,928,631
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Ownership across stages | Comparable ownership figures across stages are unavailable in this report. See Control for holdings on their disclosed basis. Open filing ↗ |
Latest available filing
- Economic
- ~44.9%*
- As of
- 2026/08/12
Relationship filters
Select for details · Vogenx
Holdings and voting rights
Holder groups may overlap; these rows are not an additive ownership partition.
| Holder / measure | Shares | Ownership | Voting rights | Reference |
|---|---|---|---|---|
| Richard CheathamBeneficial shares | 757,222 | — | — | Shares of; common stock; beneficially; owned |
| Lypul, Ltd.Beneficial shares | 657,895 | — | — | Shares of; common stock; beneficially; owned |
| Maxim Partners LLCBeneficial shares | 451,873 | — | — | Shares of; common stock; beneficially; owned |
| James GreenBeneficial shares | 1,925,555 | — | — | Shares of; common stock; beneficially; owned |
| William WilkisonBeneficial shares | 1,925,555 | — | — | Shares of; common stock; beneficially; owned |
| Steven DelmarBeneficial shares | 791,667 | — | — | Shares of; common stock; beneficially; owned |
| Peter PieracciniBeneficial shares | 23,332 | — | — | Shares of; common stock; beneficially; owned |
| Timothy BorisBeneficial shares | 23,332 | — | — | Shares of; common stock; beneficially; owned |
| Richard GormanBeneficial shares | 23,332 | — | — | Shares of; common stock; beneficially; owned |
| All executive officers and directors as a group (6 persons)Beneficial shares | 4,712,773 | — | — | Shares of; common stock; beneficially; owned |
| Richard CheathamBeneficial ownership | — | 10.5%Beneficial | — | Percentage of shares; beneficially owned; Before; offering |
| Richard CheathamBeneficial ownership | — | 5.4%Beneficial | — | Percentage of shares; beneficially owned; After; offering |
| Lypul, Ltd.Beneficial ownership | — | 9%Beneficial | — | Percentage of shares; beneficially owned; Before; offering |
| Lypul, Ltd.Beneficial ownership | — | 4.3%Beneficial | — | Percentage of shares; beneficially owned; After; offering |
| Maxim Partners LLCBeneficial ownership | — | 6.2%Beneficial | — | Percentage of shares; beneficially owned; Before; offering |
| Maxim Partners LLCBeneficial ownership | — | 3.2%Beneficial | — | Percentage of shares; beneficially owned; After; offering |
| James GreenBeneficial ownership | — | 26.5%Beneficial | — | Percentage of shares; beneficially owned; Before; offering |
| James GreenBeneficial ownership | — | 13.7%Beneficial | — | Percentage of shares; beneficially owned; After; offering |
| William WilkisonBeneficial ownership | — | 26.5%Beneficial | — | Percentage of shares; beneficially owned; Before; offering |
| William WilkisonBeneficial ownership | — | 13.7%Beneficial | — | Percentage of shares; beneficially owned; After; offering |
| Steven DelmarBeneficial ownership | — | 10.9%Beneficial | — | Percentage of shares; beneficially owned; Before; offering |
| Steven DelmarBeneficial ownership | — | 5.7%Beneficial | — | Percentage of shares; beneficially owned; After; offering |
| All executive officers and directors as a group (6 persons)Beneficial ownership | — | 62.3%Beneficial | — | Percentage of shares; beneficially owned; Before; offering |
| All executive officers and directors as a group (6 persons)Beneficial ownership | — | 33.2%Beneficial | — | Percentage of shares; beneficially owned; After; offering |
| common stockper-share voting rights | — | — | 1 vote per shareVotes per share | Literal source per-share voting entitlement; common stock; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding |
Source and calculation ↗
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: Richard Cheatham (1)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: Lypul, Ltd. (2)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: Maxim Partners LLC (3)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: James Green (4)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: William Wilkison (5)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: Steven Delmar (6)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: Peter Pieraccini (7)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: Timothy Boris (8)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: Richard Gorman (9)
Exact source ownership column: Shares of; common stock; beneficially; owned; holders may overlap; not an additive partition
Raw source column: Shares of; common stock; beneficially; owned; source holder: All executive officers and directors as a group (6 persons) (10)
Exact source ownership column: Percentage of shares; beneficially owned; Before; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; Before; offering; source holder: Richard Cheatham (1)
Exact source ownership column: Percentage of shares; beneficially owned; After; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; After; offering; source holder: Richard Cheatham (1)
Exact source ownership column: Percentage of shares; beneficially owned; Before; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; Before; offering; source holder: Lypul, Ltd. (2)
Exact source ownership column: Percentage of shares; beneficially owned; After; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; After; offering; source holder: Lypul, Ltd. (2)
Exact source ownership column: Percentage of shares; beneficially owned; Before; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; Before; offering; source holder: Maxim Partners LLC (3)
Exact source ownership column: Percentage of shares; beneficially owned; After; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; After; offering; source holder: Maxim Partners LLC (3)
Exact source ownership column: Percentage of shares; beneficially owned; Before; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; Before; offering; source holder: James Green (4)
Exact source ownership column: Percentage of shares; beneficially owned; After; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; After; offering; source holder: James Green (4)
Exact source ownership column: Percentage of shares; beneficially owned; Before; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; Before; offering; source holder: William Wilkison (5)
Exact source ownership column: Percentage of shares; beneficially owned; After; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; After; offering; source holder: William Wilkison (5)
Exact source ownership column: Percentage of shares; beneficially owned; Before; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; Before; offering; source holder: Steven Delmar (6)
Exact source ownership column: Percentage of shares; beneficially owned; After; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; After; offering; source holder: Steven Delmar (6)
Exact source ownership column: Percentage of shares; beneficially owned; Before; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; Before; offering; source holder: All executive officers and directors as a group (6 persons) (10)
Exact source ownership column: Percentage of shares; beneficially owned; After; offering; holders may overlap; not an additive partition
Raw source column: Percentage of shares; beneficially owned; After; offering; source holder: All executive officers and directors as a group (6 persons) (10)
Literal source per-share voting entitlement; common stock; subject to the express source qualifications; full source conditions retained; not a holder voting percentage, ownership amount or controller finding
The holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock do not have any cumulative voting rights. Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of shares of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine. See the section titled “Dividend Policy” for additional information. Our common stock has no preemptive rights, conversion rights or other subscription rights or redemption or sinking fund provisions.
Saved control snapshot
The dated saved report retains its own figures and assumptions. These strings are not new calculation inputs.
| Holder / measure | Shares | Ownership | Voting rights | Reference |
|---|---|---|---|---|
| Existing holdersMajor ownership group | — | ~55.1%* | — | |
| Other disclosed classesMajor ownership group | — | See filing | — | |
| IPO sharesPublic / new investors | — | 6.250M | — |
Economic ownership
A chart needs complete, non-overlapping economic interests on one date and share basis. The disclosed holder figures remain in the table.
IPO shares are immediately tradable; later supply depends on the final lock-up, option and resale-registration terms.
- Initial float
- 6.250M
- Restricted / potential supply
- 13.92M
- Multiple
- See filing
- Increase
- See filing
Share supply
Source lock-up conditions
Literal day restriction; after date of this prospectus; full conditions and exceptions remain in the source paragraph
| Measure | Reported value |
|---|---|
| Each of our directors and officers and substantially all of our stockholdersAfter date of this prospectus · Source conditions apply | 180 days |
| WeAfter date of this prospectus · Source conditions apply | 180 days |
| Our directors and executive officers and substantially all of our stockholders, or such persons, the lock-up partiesAfter date of this prospectus · Source conditions apply | 180 days |
Source and calculation
Each of our directors and officers and substantially all of our stockholders have agreed not to sell or otherwise transfer or dispose of any of our securities for a period of 180 days from the date of this prospectus, subject to certain exceptions. The representatives of the underwriters may, in their sole discretion, permit early release of shares subject to the lock-up agreements. See the section entitled “Underwriting,” included elsewhere in this prospectus for more information.
SEC lock-up paragraph; source 1491366:1491952; SHA256 99d96b3511dacd416f201346a1202d3f17cf526d4ab492ed4dd04a4a78481371 ↗We have agreed that, subject to certain exceptions, we will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the Securities and Exchange Commission a registration statement under the Securities Act relating to, any shares of our common stock or securities convertible into or exercisable or exchangeable for any shares of our common stock, or publicly disclose the intention to make any offer, sale, pledge, loan, disposition or filing, or (ii) enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with the ownership of any shares of common stock or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of shares of common stock or such other securities, in cash or otherwise), in each case without the prior written consent of Jones for a period of 180 days after the date of this prospectus, other than the shares of our common stock to be sold in this offering.
SEC lock-up paragraph; source 1538803:1540093; SHA256 7d0678f954aeb012a991e658bb32782a14563f60f1ac8cf9ddbb58f17f5fb1e4 ↗Our directors and executive officers and substantially all of our stockholders, or such persons, the lock-up parties, have entered into lock-up agreements with the underwriters pursuant to which each lock-up party, with limited exceptions, for a period of 180 days after the date of this prospectus, or such period, the restricted period, will not (and may not cause any of their direct or indirect affiliates to), without the prior written consent of Jones, (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable for our common stock (including, without limitation, common stock or such other securities which may be deemed to be beneficially owned by such lock-up parties in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or warrant, or collectively with the common stock, the lock-up securities, (2) enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of ownership of the lock-up securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of lock-up securities, in cash or otherwise, (3) make any demand for, or exercise any right with respect to, the registration of any lock-up securities, or (4) publicly disclose the intention to do any of the foregoing. Such persons or entities will be required to acknowledge that these undertakings will preclude them from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or transfer (by any person or entity, whether or not a signatory to such agreement) of any economic consequences of ownership, in whole or in part, directly or indirectly, of any lock-up securities, whether any such transaction or arrangement (or instrument provided for thereunder) would be settled by delivery of lock-up securities, in cash or otherwise.
SEC lock-up paragraph; source 1542066:1544693; SHA256 7507fb5458386d2e60ef98e502f1de59cb0fc4e1df4b416b8eac860a94689205 ↗Conditional lock-up timeline
Conditional lock-up timeline
Eligibility is not a sale. Release conditions, holder groups and exceptions remain separate.
Milestones and unconfirmed releases
| Holder / event | Term / date | Conditions |
|---|---|---|
| Over-allotment window | Post-listing See filing · Additional shares only if exercised | Over-allotment window · Additional shares only if exercised |
| Insider resale eligibility | Holder-specific See 424B · Existing-holder supply | Insider resale eligibility · Existing-holder supply |
Basis and evidence
Over-allotment window · Additional shares only if exercised
Lock-up / shares eligible for future sale ↗Insider resale eligibility · Existing-holder supply
Lock-up / shares eligible for future sale ↗Financial quality
Bars compare absolute amounts within each measure. Each measure has its own scale.
Net income / (loss)
$ · Annual values as reportedOperating cash flow
$ · Annual values as reported| Calculation | FY2024 | FY2025 |
|---|---|---|
| Net income / (loss) | ($2,203,591) | ($1,445,603) |
| Operating cash flow | ($2,341,372) | ($1,111,913) |
| Calculation | Reported value |
|---|---|
| Cash and cash equivalents2024-12-31 | $962,923 |
| Cash and cash equivalents2025-12-31 | $601,010 |
| Current assets2024-12-31 | $970,398 |
| Current assets2025-12-31 | $681,170 |
| Total assets2024-12-31 | $970,398 |
| Total assets2025-12-31 | $681,170 |
| Current liabilities2024-12-31 | $395,707 |
| Current liabilities2025-12-31 | $1,589,082 |
| Total liabilities2024-12-31 | $460,814 |
| Total liabilities2025-12-31 | $1,600,405 |
| Total equity / (deficit)2024-12-31 | $509,584 |
| Total equity / (deficit)2025-12-31 | ($919,235) |
| General and administrative expensesFY2024 · Restated | $984,309 |
| General and administrative expensesFY2025 · Restated | $867,153 |
| Cash and cash equivalents2026-03-31 · Unaudited | $250,753 |
| Current assets2026-03-31 · Unaudited | $898,459 |
| Total assets2026-03-31 · Unaudited | $898,459 |
| Current liabilities2026-03-31 · Unaudited | $2,293,752 |
| Total liabilities2026-03-31 · Unaudited | $2,297,998 |
| Total equity / (deficit)2026-03-31 · Unaudited | ($1,399,539) |
| General and administrative expenses3M ended 2025-03-31 · Unaudited | $202,886 |
| General and administrative expenses3M ended 2026-03-31 · Unaudited | $225,244 |
| Net income / (loss)3M ended 2025-03-31 · Unaudited | ($356,619) |
| Net income / (loss)3M ended 2026-03-31 · Unaudited | ($475,452) |
| Operating cash flow3M ended 2025-03-31 · Unaudited | ($387,991) |
| Operating cash flow3M ended 2026-03-31 · Unaudited | ($350,257) |
Basis and evidence
Saved snapshot — period not verified
These saved figures have no verified reporting period or currency basis. They are excluded from statement comparisons and calculations.
Financial quality
| Calculation | Reported value |
|---|---|
| Revenue | Pre-revenue |
| Net resultLatest reported | $(1.56M) |
| Market-value referencePost-listing snapshot | $410.85M |
| Shares outstandingLatest reported | 13.92M |
| Offer size6.250M | $81.25M |
Sources and calculation notes
Read this report’s SEC filing ↗
| View | Source basis |
|---|---|
| Financial review | Reported financial figures are shown above. A cash-runway estimate needs compatible cash-flow and funding assumptions. Open filing ↗ |
Baseline filing — comparison pending
No source-comparable material changes identified in this report.
Why it mattersChanges dilution, public float and potential supply.
Evidence · 424B4 · 2026/08/12Why it mattersChanges valuation, proceeds and first-day return assumptions.
Evidence · 424B4 · 2026/08/12424B4
• Final prospectus source verified
• Trading began on 2026-08-12 at $13.00
Clinical development, regulatory approval and cash-runway outcomes can change the equity value materially.
- Potential impact
- High
- Evidence
- 424B4 · 2026/08/12 ↗
The latest reported period remains loss-making.
- Potential impact
- High
- Evidence
- 424B4 · 2026/08/12 ↗
The primary-secondary mix, controlling holders and voting rights require the final beneficial-ownership table.
- Potential impact
- High
- Evidence
- 424B4 · 2026/08/12 ↗
Option exercise, employee equity and lock-up expiry can expand tradable supply.
- Potential impact
- Medium
- Evidence
- 424B4 · 2026/08/12 ↗
Sources and calculation notes
Final prospectus, offer price, listing date and headline financial evidence reconciled
View the filing's actual first page +
